×
About 625 results

ALLMedicine™ Urinary Free Cortisol Center

Research & Reviews  309 results

The usefulness of the combined high-dose dexamethasone suppression test and desmopressi...
https://doi.org/10.1507/endocrj.EJ20-0837
Endocrine Journal; Qiao J, Li J et. al.

Apr 1st, 2021 - Bilateral inferior petrosal sinus sampling (BIPSS) is the current gold standard test for differentially diagnosing ACTH-dependent Cushing's syndrome (CS). However, BIPSS is an invasive procedure, and its availability is limited. We retrospectively...

Biochemical diagnosis of Cushing's disease: Screening and confirmatory testing.
https://doi.org/10.1016/j.beem.2021.101519
Best Practice & Research. Clinical Endocrinology & Metabo... Petersenn S

Mar 24th, 2021 - Due to the variable clinical features and its rarity diagnosis of Cushing's disease (CD) is often delayed. Clearly, awareness for CD needs to be raised, accompanied by the availability of simple and accurate screening tests. Late-night salivary co...

Clinical course and outcome of patients with ACTH-dependent Cushing's syndrome infected...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955209
Endocrine Belaya Z, Golounina O et. al.

Mar 13th, 2021 - To analyze the clinical presentations of patients with endogenous Cushing's syndrome (CS) affected by Coronavirus disease-19 (COVID-19). Patients who were referred to our clinic with active CS from 31st March to 15th May 2020 were screened for COV...

Anxiety and depressive symptoms effects on cortisol trajectories from pregnancy to post...
https://doi.org/10.1016/j.yhbeh.2020.104917
Hormones and Behavior; Conde A, Costa R et. al.

Jan 2nd, 2021 - Anxiety and depressive symptoms may influence cortisol trajectories in women and men during pregnancy and the postpartum period. Using a multilevel approach, anxiety and depressive symptoms effects on 24-hour urinary free cortisol trajectories fro...

see more →

Clinicaltrials.gov  313 results

The usefulness of the combined high-dose dexamethasone suppression test and desmopressi...
https://doi.org/10.1507/endocrj.EJ20-0837
Endocrine Journal; Qiao J, Li J et. al.

Apr 1st, 2021 - Bilateral inferior petrosal sinus sampling (BIPSS) is the current gold standard test for differentially diagnosing ACTH-dependent Cushing's syndrome (CS). However, BIPSS is an invasive procedure, and its availability is limited. We retrospectively...

Biochemical diagnosis of Cushing's disease: Screening and confirmatory testing.
https://doi.org/10.1016/j.beem.2021.101519
Best Practice & Research. Clinical Endocrinology & Metabo... Petersenn S

Mar 24th, 2021 - Due to the variable clinical features and its rarity diagnosis of Cushing's disease (CD) is often delayed. Clearly, awareness for CD needs to be raised, accompanied by the availability of simple and accurate screening tests. Late-night salivary co...

Clinical course and outcome of patients with ACTH-dependent Cushing's syndrome infected...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955209
Endocrine Belaya Z, Golounina O et. al.

Mar 13th, 2021 - To analyze the clinical presentations of patients with endogenous Cushing's syndrome (CS) affected by Coronavirus disease-19 (COVID-19). Patients who were referred to our clinic with active CS from 31st March to 15th May 2020 were screened for COV...

Anxiety and depressive symptoms effects on cortisol trajectories from pregnancy to post...
https://doi.org/10.1016/j.yhbeh.2020.104917
Hormones and Behavior; Conde A, Costa R et. al.

Jan 2nd, 2021 - Anxiety and depressive symptoms may influence cortisol trajectories in women and men during pregnancy and the postpartum period. Using a multilevel approach, anxiety and depressive symptoms effects on 24-hour urinary free cortisol trajectories fro...

see more →

News  3 results

Osilodrostat Holds Promise for Treating Cushing's Disease
https://www.staging.medscape.com/viewarticle/878215

Apr 4th, 2017 - ORLANDO, Florida — The investigational drug osilodrostat (Novartis) is showing promise for the treatment of Cushing's disease. Osilodrostat is an orally active inhibitor of 11ß-hydroxylase, the enzyme that catalyzes the last step of cortisol biosy...

Osilodrostat Holds Promise for Treating Cushing's Disease
https://www.medscape.com/viewarticle/878215

Apr 4th, 2017 - ORLANDO, Florida — The investigational drug osilodrostat (Novartis) is showing promise for the treatment of Cushing's disease. Osilodrostat is an orally active inhibitor of 11ß-hydroxylase, the enzyme that catalyzes the last step of cortisol biosy...

VIDEO: Use late-night salivary cortisol to catch recurrent Cushing’s
https://www.mdedge.com/endocrinology/article/84289/pituitary-thyroid-adrenal-disorders/video-use-late-night-salivary
M. Alexander Otto

Jul 3rd, 2014 - CHICAGO – Late-night salivary cortisol exceeded normal limits in 10 women with recurrent Cushing’s disease a mean of 3. 5 years after transsphenoidal surgery, but their urinary free cortisol remained in normal limits, according to a retrospective r.

see more →